|
Delayed
Australian S.E.
02:10:27 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.0110 AUD | +4.76% |
|
+10.00% | -21.43% |
| 08-31 | Algorae Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 07-14 | Algorae Pharmaceuticals Limited Announces Board Changes, Effective July 14, 2026 | CI |
Company Valuation: Algorae Pharmaceuticals Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 6.857 | 10.28 | 23.4 | 16.87 | 8.437 | 20.26 |
| Change | - | 49.95% | 127.61% | -27.9% | -50% | 140.08% |
| Enterprise Value (EV) 1 | 5.244 | 6.043 | 19.29 | 13.77 | 6.118 | 16.32 |
| Change | - | 15.22% | 219.24% | -28.64% | -55.56% | 166.74% |
| P/E | -4.62x | -3.58x | -9.38x | -7.7x | -10x | -6.55x |
| PBR | 4.98x | 2.55x | 6.22x | 5.6x | 3.79x | 4.76x |
| PEG | - | 0.3x | 0.3x | 0.4x | 0.2x | -0x |
| Capitalization / Revenue | 25.6x | 3,020x | 557x | - | - | - |
| EV / Revenue | 19.6x | 1,775x | 459x | - | - | - |
| EV / EBITDA | -3.92x | -4.14x | -15.2x | -8.08x | - | - |
| EV / EBIT | -3.91x | -4.14x | -15.2x | -8.07x | -5.74x | -7.12x |
| EV / FCF | -7.14x | -6.03x | -29.7x | -24.8x | -9.61x | -11.9x |
| FCF Yield | -14% | -16.6% | -3.36% | -4.03% | -10.4% | -8.42% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0026 | -0.002235 | -0.0016 | -0.001299 | -0.000499 | -0.001527 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 0.2682 | 0.003405 | 0.042 | - | - | - |
| EBITDA 1 | -1.336 | -1.459 | -1.267 | -1.704 | - | - |
| EBIT 1 | -1.341 | -1.46 | -1.268 | -1.705 | -1.067 | -2.293 |
| Net income 1 | -1.461 | -1.957 | -2.108 | -2.096 | -0.803 | -2.711 |
| Net Debt 1 | -1.612 | -4.239 | -4.111 | -3.108 | -2.319 | -3.937 |
| Reference price 2 | 0.0120 | 0.0080 | 0.0150 | 0.0100 | 0.0050 | 0.0100 |
| Nbr of stocks (in thousands) | 571,441 | 1,285,364 | 1,560,145 | 1,687,395 | 1,687,395 | 2,025,571 |
| Announcement Date | 8/30/21 | 8/31/22 | 8/30/23 | 8/30/24 | 8/28/25 | 8/31/26 |
1AUD in Million2AUD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 16.08M | |
| 20.25x | 7.04x | 14.2x | 1.45% | 67.98B | |
| 36.9x | 9.64x | 29.44x | 0.04% | 64.94B | |
| -77.3x | 14.92x | -71.95x | -.--% | 27.58B | |
| -15.85x | 6.12x | -7.7x | -.--% | 26.06B | |
| 29.69x | 6.35x | 16.48x | -.--% | 25.74B | |
| 27.41x | 5.13x | 17.06x | -.--% | 20.09B | |
| 49.41x | 18.23x | 36.98x | 0.31% | 17.16B | |
| 1289.22x | 37.23x | 812.54x | -.--% | 14.92B | |
| 18.23x | 5.44x | 12.69x | -.--% | 14.62B | |
| Average | 153.11x | 12.23x | 95.53x | 0.2% | 27.91B | |
| Weighted average by Cap. | 82.01x | 10.35x | 51.60x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 1AI Stock
- Valuation Algorae Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
